Acute Lymphoblastic Leukemia: Challenges in MRD Testing
2 vistas
• 08/04/23
0
0
Empotrar
administrator
Suscriptores
Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios